Form 4 Tracker
MoonLake Immunotherapeutics
MLTX

13 insider filings · Latest: Jun 22, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 3, 2025Jul 3 5:23 PMMoukheibir Catherine
Proposed Sale
23,500$48.79$1.1M

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 17, 2026Jun 22 8:50 PMP/Il L Bvf PartnersDirector, 10% Owner
Grant/Award
22,195$19.1922,195(I)

View →

Jun 17, 2026Jun 18 10:45 PMAndrew John PhillipsDirector
Grant/Award
22,195$19.1922,195(D)

View →

Jun 17, 2026Jun 18 10:45 PMSpike LoyDirector
Grant/Award
22,195$19.1922,195(D)

View →

Jun 17, 2026Jun 18 10:45 PMCatherine MoukheibirDirector
Grant/Award
22,195$19.1922,195(D)

View →

Jun 17, 2026Jun 18 10:45 PMRamnik XavierDirector
Grant/Award
22,195$19.1922,195(D)

View →